Trademark Details For SHEQU (Serial Number 86854629)

  •  Home
  •  Print
SHEQU
0
0
0
0
word.basic_information
Serial Number  United States - USPTO 86854629
Registration Number 5127037
Mark
SHEQU
Filing Date Dec-18-2015
Status
Registered  
SECTION 8-AC.. (701)
SECTION 8-ACCEPTED
Attorney Name
TTAB
0
Action Tags
  


  • GUANGDONG XISE INDUSTRIAL CO., LTD.

  • Color(s) Claimed:

005Pharmaceuticals

U.S Class(es): 006, 018, 044, 046, 051, 052

Class Status: Active

First Use: Aug-13-2014

First Use in Commerce: Aug-13-2014

010Medical apparatus

U.S Class(es): 026, 039, 044

Class Status: Active

First Use: Jan-02-2014

First Use in Commerce: Jan-02-2014





Correspondences

NameBen Natter
AddressHaug Partners LLP 745 Fifth Avenue New York NY 10151

Prosecution History

  
USPTO 
DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Dec-22-2015NEW APPLICATION ENTERED   NWAPI
Dec-29-2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED   NWOSI
Apr-05-2016ASSIGNED TO EXAMINER   DOCKD
Apr-06-2016
NON-FINAL ACTION WRITTEN
  
CNRTR
Apr-06-2016NON-FINAL ACTION E-MAILED   GNRTF
Apr-06-2016
NOTIFICATION OF NON-FINAL ACTION E-MAILED
  
GNRNO
Sep-17-2016TEAS RESPONSE TO OFFICE ACTION RECEIVED   TROAI
Sep-29-2016ASSIGNED TO LIE   ALIEA
Sep-29-2016CORRESPONDENCE RECEIVED IN LAW OFFICE   CRFAI
Sep-29-2016TEAS/EMAIL CORRESPONDENCE ENTERED   TEMEI
Oct-01-2016APPROVED FOR PUB - PRINCIPAL REGISTER   CNSAO
Oct-04-2016LAW OFFICE PUBLICATION REVIEW COMPLETED   PREVO
Oct-19-2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED   NONPE
Nov-08-2016PUBLISHED FOR OPPOSITION   PUBOA
Nov-08-2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED   NPUBE
Jan-24-2017REGISTERED-PRINCIPAL REGISTER   R.PRA
Jan-24-2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED   REM1E
Dec-19-2022TEAS SECTION 8 RECEIVED   ES8RI
Jun-13-2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL   APREA
Jun-15-2023REGISTERED - SEC. 8 (6-YR) ACCEPTED   8.OKO
Jun-15-2023NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED   NAS8E